SELLAS Life Sciences (SLS) Liabilities from Discontinued Operations (2014 - 2017)

SELLAS Life Sciences (SLS) has 4 years of Liabilities from Discontinued Operations data on file, last reported at 6759000.0 in Q3 2017.

• On a quarterly basis, Liabilities from Discontinued Operations rose 61.12% year-over-year to 6759000.0 in Q3 2017; TTM through Sep 2017 was 6759000.0, a 61.12% increase from a year earlier, with the FY2016 full-year figure at 6059000.0, up 2.26% from the prior year.
• Liabilities from Discontinued Operations for Q3 2017 stood at 6759000.0, down from 8685000.0 in the prior quarter.
• Over the last five years, Liabilities from Discontinued Operations for SLS reached as high as 10045000.0 in Q1 2017 and fell as low as 3727000.0 in Q2 2016.
• Historically, Liabilities from Discontinued Operations has averaged 6474800.0 across 4 years, with a median of 6409000.0 in 2016.
• Across the five-year window, Liabilities from Discontinued Operations sank 45.5% in 2016 and surged 133.03% in 2017, its largest moves.
• Year by year, Liabilities from Discontinued Operations stood at 7169000.0 in 2014, then dropped by 17.35% to 5925000.0 in 2015, then rose by 2.26% to 6059000.0 in 2016, then advanced by 11.55% to 6759000.0 in 2017.
• Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were 6759000.0 in Q3 2017, 8685000.0 in Q2 2017, and 10045000.0 in Q1 2017.